Figure 2
From: Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty

Nephrologist responses to clinical equipoise and willingness to enroll patients in randomized controlled trial.
From: Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
Nephrologist responses to clinical equipoise and willingness to enroll patients in randomized controlled trial.